Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 617

1.

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.

Gold J, Marta M, Meier UC, Christensen T, Miller D, Altmann D, Holden D, Bianchi L, Adiutori R, MacManus D, Yousry T, Schmierer K, Turner B, Giovannoni G.

Mult Scler Relat Disord. 2018 Jun 28;24:123-128. doi: 10.1016/j.msard.2018.06.002. [Epub ahead of print]

PMID:
29990894
2.

CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?

Veenstra M, Byrd DA, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L, Li M, Gama L, León-Rivera R, Calderon TM, Clements JE, Morgello S, Berman JW.

J Neuroimmune Pharmacol. 2018 Jul 6. doi: 10.1007/s11481-018-9792-7. [Epub ahead of print]

PMID:
29981000
3.

Nabilone for Chronic Pain Management: A Review of Clinical Effectiveness and Guidelines [Internet].

Kim J, Grobelna A.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug 9.

4.

Prospective memory in clinical populations.

Raskin SA.

Clin Neuropsychol. 2018 Jul;32(5):741-747. doi: 10.1080/13854046.2018.1484519.

PMID:
29936902
5.

Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy.

Kang Y, Cai Y.

AIDS Res Hum Retroviruses. 2018 Jul 9. doi: 10.1089/AID.2017.0268. [Epub ahead of print]

PMID:
29877092
6.

Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation.

Leal FE, Menezes SM, Costa EAS, Brailey PM, Gama L, Segurado AC, Kallas EG, Nixon DF, Dierckx T, Khouri R, Vercauteren J, Galvão-Castro B, Saraiva Raposo RA, Van Weyenbergh J.

Front Microbiol. 2018 May 22;9:985. doi: 10.3389/fmicb.2018.00985. eCollection 2018.

7.

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Plantone D, Koudriavtseva T.

Clin Drug Investig. 2018 May 8. doi: 10.1007/s40261-018-0656-y. [Epub ahead of print] Review.

PMID:
29737455
8.

The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.

Rotem E, Faingold O, Charni M, Klug YA, Harari D, Shmuel-Galia L, Nudelman A, Rotter V, Shai Y.

PLoS Pathog. 2018 May 4;14(5):e1007044. doi: 10.1371/journal.ppat.1007044. eCollection 2018 May.

9.

Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases.

Enose-Akahata Y, Azodi S, Smith BR, Billioux BJ, Vellucci A, Ngouth N, Tanaka Y, Ohayon J, Cortese I, Nath A, Jacobson S.

PLoS Pathog. 2018 Apr 30;14(4):e1007042. doi: 10.1371/journal.ppat.1007042. eCollection 2018 Apr.

10.

[Cannabinoid therapy in practice].

Rasche T, Emmert D, Stieber C, Mücke M, Conrad R.

Urologe A. 2018 May;57(5):558-562. doi: 10.1007/s00120-018-0636-0. Review. German.

PMID:
29651709
11.

Could antiretrovirals be treating EBV in MS? A case report.

Drosu NC, Edelman ER, Housman DE.

Mult Scler Relat Disord. 2018 May;22:19-21. doi: 10.1016/j.msard.2018.02.029. Epub 2018 Feb 27.

12.

Multiple sclerosis and HIV: a case of multiple sclerosis-immune reconstitution inflammatory syndrome associated with antiretroviral therapy initiation.

Anand P, Saylor D.

Int J STD AIDS. 2018 Aug;29(9):929-932. doi: 10.1177/0956462418754972. Epub 2018 Feb 21.

PMID:
29466918
13.

Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: A novel neuro-immune axis.

Chiou B, Lucassen E, Sather M, Kallianpur A, Connor J.

Glia. 2018 Jul;66(7):1317-1330. doi: 10.1002/glia.23313. Epub 2018 Feb 19.

PMID:
29457657
14.

Diffusion Kurtosis Imaging Shows Similar Cerebral Axonal Damage in Patients with HIV Infection and Multiple Sclerosis.

Buyukturkoglu K, Fleyser L, Byrd D, Morgello S, Inglese M.

J Neuroimaging. 2018 May;28(3):320-327. doi: 10.1111/jon.12497. Epub 2018 Jan 30.

PMID:
29380545
15.

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Sweeney MD, Sagare AP, Zlokovic BV.

Nat Rev Neurol. 2018 Mar;14(3):133-150. doi: 10.1038/nrneurol.2017.188. Epub 2018 Jan 29. Review.

PMID:
29377008
16.

Influenza Vaccination of Elderly and People with Chronic Illness [Internet].

Vist GE, Sæterdal I, Johansen M, Riise Berg M, Hauge SH, Fretheim A.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2009 May.

17.

The health impact of residential retreats: a systematic review.

Naidoo D, Schembri A, Cohen M.

BMC Complement Altern Med. 2018 Jan 10;18(1):8. doi: 10.1186/s12906-017-2078-4. Review.

18.

Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge.

Naeem SB, Niazi F, Baig A, Sadiq H, Sattar M.

J Coll Physicians Surg Pak. 2018 Jan;28(1):66-68. doi: 10.29271/jcpsp.2018.01.66.

PMID:
29290197
19.
20.

Integrins: Integrating the Biology and Therapy of Cell-cell Interactions.

Pandolfi F, Franza L, Altamura S, Mandolini C, Cianci R, Ansari A, Kurnick JT.

Clin Ther. 2017 Dec;39(12):2420-2436. doi: 10.1016/j.clinthera.2017.11.002. Epub 2017 Dec 6. Review.

PMID:
29203050

Supplemental Content

Loading ...
Support Center